#AstraZeneca buys respiratory #vaccine developer Icosavax in $1.1 billion deal
#RSV #RSVvaccines
https://news.yahoo.com/astrazeneca-buy-rsv-vaccine-maker-071553622.html
#RSV #RSVvaccines
https://news.yahoo.com/astrazeneca-buy-rsv-vaccine-maker-071553622.html
Yahoo News
AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 billion deal
AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion. Icosavax is developing a combination vaccine candidate targeting RSV and human metapneumovirus (hMPV). RSV…
#RSVvaccines may be linked to small increased risk of developing #GuillainBarréSyndrome, data suggest
#InformedConsent
https://www.statnews.com/2024/02/29/rsv-vaccines-may-be-linked-to-small-increased-risk-of-developing-guillain-barre-syndrome/
#InformedConsent
https://www.statnews.com/2024/02/29/rsv-vaccines-may-be-linked-to-small-increased-risk-of-developing-guillain-barre-syndrome/
STAT
RSV vaccines may be linked to small increased risk of developing Guillain-Barré syndrome, data suggest
The new vaccines that protect older adults against RSV may be linked to a small increased risk of developing Guillain-Barré syndrome, new data suggest.
The trial showed that there was a slight but increased risk in preterm labor as well as an increase in neonatal death in the group of very small numbers.
#RSVvaccines #Pregnancy #Vaccines #GlaxoSmithKline
https://www.medscape.com/viewarticle/risk-preterm-birth-stops-maternal-rsv-vaccine-trial-2024a10004rk?form=fpf
#RSVvaccines #Pregnancy #Vaccines #GlaxoSmithKline
https://www.medscape.com/viewarticle/risk-preterm-birth-stops-maternal-rsv-vaccine-trial-2024a10004rk?form=fpf
Medscape
Risk for Preterm Birth Stops Maternal RSV Vaccine Trial
With a maternal vaccine already on the market to protect newborns from RSV, the outlook for another looked promising, but latest phase 3 trial of a new candidate is now halted over safety concerns.
Guillain-Barre syndrome 'more common than expected' with RSV vaccine in older people, CDC reiterates
#Vaccines #RSVvaccines #InformedConsent
https://www.yahoo.com/news/guillain-barre-syndrome-more-common-171140815.html
#Vaccines #RSVvaccines #InformedConsent
https://www.yahoo.com/news/guillain-barre-syndrome-more-common-171140815.html
Yahoo News
Guillain-Barre syndrome 'more common than expected' with RSV vaccine in older people, CDC reiterates
Reports of a rare nervous system disorder were “more common than expected” in older U.S. adults who got the new RSV vaccines, according to a Centers for Disease Control and Prevention report released Thursday that's similar to what the organization said earlier…
"...the vaccine may slightly increase the risk of a rare side effect that can sometimes lead to paralysis or death."
#RSVvaccines #RSV #Vaccines #GuillainBarreSyndrome #InformedConsent #Healthcare
https://www.livescience.com/health/medicine-drugs/cdc-issues-new-guidelines-for-rsv-vaccines-citing-side-effect-concerns
#RSVvaccines #RSV #Vaccines #GuillainBarreSyndrome #InformedConsent #Healthcare
https://www.livescience.com/health/medicine-drugs/cdc-issues-new-guidelines-for-rsv-vaccines-citing-side-effect-concerns
livescience.com
CDC issues new guidelines for RSV vaccines, citing side-effect concerns
The CDC has clarified and narrowed its recommendations for which older adults should get an RSV vaccine.